Impact of steatosis on perioperative outcome following hepatic resection

被引:350
作者
Kooby, DA
Fong, Y
Suriawinata, A
Gonen, M
Allen, PJ
Klimstra, DS
DeMatteo, RP
D'Angelica, M
Blumgart, LH
Jarnagin, WR
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
chemotherapy; surgical complications; nonalcoholic steatohepatitis; infection;
D O I
10.1016/j.gassur.2003.09.012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Fatty liver disease may interfere with liver regeneration and is postulated to result in an adverse outcome for patients subjected to partial hepatectomy. This study examines the impact of steatosis on outcome following hepatic resection for neoplasms.. All patients with fatty livers (n = 325) who under-went hepatectomy between December 1991 and September 2001 were identified from a prospective database. Slides were reviewed and steatosis was quantified as follows: <30% (mild) and greater than or equal to30% (marked). Patient data were gathered and compared with results in 160 control patients with normal livers; subjects were matched for age, comorbidity, and extent of liver resection. There were 223 patients with mild and 102 with marked steatosis. Those with steatosis were more likely to be men (59% marked vs. 55% mild vs. 43% control; P = 0.01) with a higher body mass index (29.7 +/- 5.5 marked vs. 28.2 +/- 5.5 mild vs. 26.0 +/- 5.4 control; P < 0.01), and treated preoperatively with chemotherapy (66% marked vs. 55% mild vs. 38% control; P < 0.01). Total (62%, 48%, and 35%; P < 0.01) and infective (43%, 24%, and 14%; P < 0.01) complications correlated with the degree of steatosis. No difference was observed in complications requiring major medical intervention, hospitalization, or admission to the intensive care unit between groups. On multivariate analysis, steatosis was an independent predictor of complications (P < 0.01, risk ratio = 3.04, 95% confidence interval = 1.7 to 5.54). There was a nonsignificant trend toward higher 60-day mortality in patients with marked steatosis who had lobe or more resections (9.4% marked vs. 5.0% mild vs. 5.0% control; P = 0.30). Marked steatosis is an independent predictor of complications following hepatic resection but does not have a significant impact on 60-day mortality. Steatosis alone should not preclude aggressive hepatic resection for neoplasms when indicated; however, patients with marked steatosis undergoing large resections should still be approached with due caution. (C) 2003 The Society for Surgery of the Alimentary Tract.
引用
收藏
页码:1034 / 1043
页数:10
相关论文
共 48 条
  • [1] ADAM R, 1991, TRANSPLANT P, V23, P1538
  • [2] FATTY LIVER HEPATITIS AND CIRRHOSIS IN OBESE PATIENTS
    ADLER, M
    SCHAFFNER, F
    [J]. AMERICAN JOURNAL OF MEDICINE, 1979, 67 (05) : 811 - 816
  • [3] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [4] Hepatic Steatosis as a Potential Risk Factor for Major Hepatic Resection
    Behrns K.E.
    Tsiotos G.G.
    DeSouza N.F.
    Krishna M.K.
    Ludwig J.
    Nagorney D.M.
    [J]. Journal of Gastrointestinal Surgery, 1998, 2 (3) : 292 - 298
  • [5] Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection
    Belghiti, J
    Hiramatsu, K
    Benoist, S
    Massault, PP
    Sauvanet, A
    Farges, O
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 191 (01) : 38 - 46
  • [6] LIVER STEATOSIS AND LIVER RESECTION
    BENGMAR.S
    [J]. DIGESTION, 1969, 2 (05) : 304 - &
  • [7] BISMUTH H, 1993, TRANSPLANT P, V25, P1066
  • [8] Body-mass index and mortality in a prospective cohort of US adults
    Calle, EE
    Thun, MJ
    Petrelli, JM
    Rodriguez, C
    Heath, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) : 1097 - 1105
  • [9] Is a fatty liver dangerous for transplantation?
    Canelo, R
    Braun, F
    Sattler, B
    Klinge, B
    Lorf, T
    Ramadori, G
    Ringe, B
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 414 - 415
  • [10] DALESSANDRO AM, 1991, TRANSPLANT P, V23, P1536